Back

Microbio - Environmental monitoring - plate incubation (aerobic)

Invisible microorganizms float through cleanroom air and settle on critical surfaces, threatening product sterility with each unauthorized intrusion - without systematic monitoring, contamination remains undetected until products fail sterility testing or patients develop infections. Environmental monitoring plate incubation for aerobic organizms provides the fundamental surveillance data ensuring that cleanroom classifications remain within specified limits and manufacturing environments maintain microbiological control essential for pharmaceutical and medical device production quality assurance. This contact and settle plate methodology following ISO 14644-1, ISO 14698-1, ISO 14698-2, and EU GMP guidelines quantifies viable particulates in controlled environments, establishing baseline conditions, detecting contamination events, and trending environmental performance over time. Pharmaceutical manufacturing facilities require continuous environmental monitoring demonstrating that classified areas consistently meet grade-specific contamination limits throughout production campaigns, with documented monitoring supporting regulatory submissions and inspection readiness. Medical device manufacturers operating under ISO 13485 maintain environmental monitoring programs appropriate to product contamination risk, with sterile device production demanding stringent cleanroom classifications verified through systematic viable particle monitoring using settle plates capturing airborne organizms and contact plates assessing surface contamination. The TSA incubation protocol optimized for recovery of common environmental flora - including personnel-associated organizms, water-borne bacteria, and environmental fungi - ensures comprehensive contamination detection spanning the spectrum of organizms encountered in controlled manufacturing areas. Testing frequency and location selection reflect contamination risk assessment, with critical areas near sterile operations requiring intensive monitoring while supporting areas employ risk-proportionate surveillance.

No.
100401
Method
Contact/settle plates, TSA incubation 3-5d at 30-35°C
Standard
Ph.Eur. 5.1.9, USP 1116, ISO 14644-1, ISO 14698-1, ISO 14698-2
Sample type
Environmental sample
Sample requirement (type)
Non-sterile required
Sample quantities
1 product
Equipment
Manual counting
Lead Time Standard (Days)
10
Lead Time Express (Days)
5
Lead Time Super Express (Days)
unavailable
Accredited
Yes
Test facility
In House
GLP
No
Add this test to cart to request an offer.

Do you need some help?

Other similar tests

USP 1116, ISO 14644-1
Microbio - Environmental monitoring - non-viable particles

Particle counts invisible to the naked eye determine whether pharmaceutical manufacturing areas meet regulatory classifications - exceeding limits triggers investigations, production delays, and questions about product quality that cascade through entire operations. Non-viable particle monitoring using laser particle counting technology provides real-time cleanroom classification verification essential for pharmaceutical and medical device manufacturing environments where particulate contamination threatens product quality and regulatory compliance. This optical methodology following ISO 14644-1, ISO 14698-1, and ISO 21501-3 standards quantifies airborne particles at 0.3 and 5.0 micron size channels, establishing whether controlled environments meet specified cleanliness classifications throughout production operations, interventions, and at-rest conditions. Cleanroom classification requires documented particle counting demonstrating that air filtration systems consistently deliver the designed cleanliness level, with initial qualification establishing baseline performance and periodic re-qualification verifying sustained compliance over facility lifecycle. Pharmaceutical aseptic processing demands continuous or frequent particle monitoring in Grade A critical zones, providing real-time contamination detection that triggers investigations when particle levels exceed action limits during sterile operations. Medical device manufacturers producing implantables, contact lenses, or other contamination-sensitive products employ particle counting to validate that manufacturing environments meet product-specific cleanliness requirements, with test frequency reflecting contamination risk and regulatory expectations. The dual-channel measurement enables both classification per ISO 14644-1 cleanliness classes and detection of contamination events generating elevated large particle counts indicating filter failures, procedural breaches, or material introduction problems.
View more